BCL2 and Burkitt lymphoma: This result was consistent with the findings reported by Wang et al. [36], where reduced Bcl-2 was observed in human Burkitt lymphoma cell lines (Daudi cells and Ramos cells) upon induction of apoptosis using anti-CD20 monoclonal antibody (Rituximab) conjugated with MMAE.